Intellia Therapeutics Inc buy Barclays PLC
Start price
04.08.23
/
50%
€36.00
Target price
04.08.24
€81.52
Performance (%)
-36.67%
Price
17:23
€22.80
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Intellia Therapeutics Inc is performing very badly with a performance of -36.67%. This prediction currently runs until 04.08.24. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -0.810% | -0.810% |
iShares Core DAX® | 0.410% | -2.543% |
iShares Nasdaq 100 | -2.154% | 4.721% |
iShares Nikkei 225® | -0.066% | -0.307% |
iShares S&P 500 | -0.527% | 3.848% |
Comments by Barclays_PLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Barclays PLC from $148.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat